- Home
- XTNT vs RAND Comparison
XTNT vs RAND Comparison
Compare XTNT & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- RAND
- Stock Information
- Founded
- XTNT N/A
- RAND 1969
- Country
- XTNT United States
- RAND United States
- Employees
- XTNT N/A
- RAND N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- RAND Finance: Consumer Services
- Sector
- XTNT Health Care
- RAND Finance
- Exchange
- XTNT Nasdaq
- RAND Nasdaq
- Market Cap
- XTNT 60.9M
- RAND 52.9M
- IPO Year
- XTNT N/A
- RAND N/A
- Fundamental
- Price
- XTNT $0.45
- RAND $19.80
- Analyst Decision
- XTNT Strong Buy
- RAND
- Analyst Count
- XTNT 1
- RAND 0
- Target Price
- XTNT $3.00
- RAND N/A
- AVG Volume (30 Days)
- XTNT 66.0K
- RAND 8.3K
- Earning Date
- XTNT 05-14-2025
- RAND 05-12-2025
- Dividend Yield
- XTNT N/A
- RAND 25.61%
- EPS Growth
- XTNT N/A
- RAND 35.26
- EPS
- XTNT N/A
- RAND 3.42
- Revenue
- XTNT $117,267,000.00
- RAND $8,559,285.00
- Revenue This Year
- XTNT $15.56
- RAND N/A
- Revenue Next Year
- XTNT $22.39
- RAND N/A
- P/E Ratio
- XTNT N/A
- RAND $5.73
- Revenue Growth
- XTNT 28.44
- RAND 16.64
- 52 Week Low
- XTNT $0.33
- RAND $13.69
- 52 Week High
- XTNT $0.97
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- XTNT 49.25
- RAND 51.16
- Support Level
- XTNT $0.34
- RAND $18.85
- Resistance Level
- XTNT $0.43
- RAND $21.30
- Average True Range (ATR)
- XTNT 0.05
- RAND 1.55
- MACD
- XTNT 0.01
- RAND 0.33
- Stochastic Oscillator
- XTNT 68.75
- RAND 70.53
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.